Skip to main content

Decreasing phosphodiesterase 5A activity contributes to platelet cGMP accumulation during storage of apheresis-derived platelet concentrates.

Kobsar A, Putz E, Yilmaz P, Weinig E, Boeck M, Koessler J

Publication: Transfusion (2014) • Vol 54 • Page 1008-14PMID: 23909451View on PubMed

Purpose

The purpose of this paper was to determine the effects of collection method and storage on cyclic nucleotide dependent signaling in platelet (Plt) concentrates (PC).

Conclusion

There were no differences in vasodilator-stimulated phosphoprotein (VASP) phosphorylation at ser 239 and 157, cyclic adenosine monophosphate (cAMP), cyclic guanosine monophosphate (cGMP) or phosphodiesterase 5A (PDE5A) levels between Plts obtained from whole blood and those obtained by apheresis. During storage of PC, VASP phosphorylation at ser 239 and 157 and cGMP levels increased while PDE5A levels and activity, thrombin receptor activator peptide 6 (TRAP-6)-stimulated fibrinogen binding and Plt aggregation decreased.

Studies (1)

Purpose

The purpose of this study was to determine the effects of collection method (apheresis versus venipuncture) and storage duration on cyclic nucleotide dependent signaling in PC. Whole blood was collected from 7 healthy individuals into citrate buffer, and following blood donation, apheresis plts were collected into acid citrate dextrose. Plts were obtained from whole blood through centrifugation and were resuspended in HEPES buffer. Storage is assumed to be at room temperature.

Summary of Findings

There were no differences in VASP phosphorylation at ser 239 and 157, or cAMP, cGMP or PDE5A levels between Plts obtained from whole blood and those obtained by apheresis. Compared to day 0, VASP phosphorylation at ser 239 and 157 increased by 87% and 15%, respectively, in apheresis PC stored for 2 days (p<0.05, both), and larger increases were noted after 5 days. During storage of PC, cGMP increased, reaching significance on day 5 (56%) compared to day 0 (p<0.05), but cAMP levels were unaffected by storage of PC. Compared to day 0, PDE5A protein and activity levels were 30% and 17% lower, respectively, on day 2 (p<0.05, both) and 40% and 23% lower, respectively, on day 5 (p<0.05, both). TRAP-6-stimulated fibrinogen binding decreased by 23.5% on day 5 compared to day 0 (p<0.05), and Plt aggregation decreased by 48% on day 5 compared to day 0 (p<0.05).
  • Biospecimens

    FluidBlood
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Normal
  • Platforms

    ProteinWestern blot
    ProteinEnzyme assay
    Small moleculeELISA
    Cell count/volumeFlow cytometry
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionMethod of fluid acquisition
    Apheresis
    Venipuncture
    StorageTime at room temperature
    0 days
    2 days
    5 days